Compare 10X Genomics Inc (TXG) vs Visa Inc (V) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Visa Inc — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while Visa Inc trades at $356.3 (market cap $685.71B). The key difference: Visa Inc is far larger — about 125.1× 10X Genomics Inc's market cap, and Visa Inc pays a 0.74% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TXG | V | |
|---|---|---|
Market Cap | $5.48B | $685.71B |
Sector | Health | Financials |
52-Week High | $45.80 | $365.14 |
52-Week Low | $11.34 | $295.52 |
Enterprise Value | $5.02B | $696.30B |
Volume | — | 10,431,336 |
Dividend Yield | — | 0.74% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Visa (V) trades at $355.82, down 0.76% on the day, with a bullish technical outlook supported by moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $3.31 exceeding the $3.10 estimate. Revenue growth remains robust, reaching $40B in 2025, and profitability is high with a net income margin of 51.68%. Recent news highlights Visa's focus on AI-driven commerce and stablecoin partnerships, positioning it for future payment innovations.
The stock offers a compelling long-term investment case with 85% analyst buy ratings and a $396.70 consensus price target, implying 11% upside. Key risks include competitive threats from fintech and regulatory pressures. Visa's strong cash flow and dividend payments provide shareholder value, but investors should monitor execution on AI initiatives and macroeconomic impacts on consumer spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →
